REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

09/12/2022 11:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221209:nRSI2420Ja&default-theme=true

RNS Number : 2420J  Smith & Nephew Plc  09 December 2022

SMITH & NEPHEW PLC

 

9 December 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

On 8 December 2022, the following award of US$0.20 ordinary shares (the
"Shares") in Smith & Nephew plc (the "Company") vested under an award
agreement to Deepak Nath.

 

VESTING OF A PERFORMANCE AWARD GRANTED UNDER THE AWARD AGREEMENT DATED 29
APRIL 2022

 

As set out in the announcement published on 3 May 2022, a Performance Award
over 127,461 shares was granted to Deepak Nath with an expected vest date of 9
November 2022. The vest of this award was subject to the performance
conditions applicable to the performance stock award over Siemens Healthineers
AG ("SH") shares originally granted to Deepak Nath by SH on 9 November 2018.

 

In accordance with the terms of the award agreement, the expected vest date of
9 November 2022 was delayed so that the applicable performance criteria
attaching to the Performance Award could be measured against the financial
results of SH which were announced on 23 November 2022. It has been determined
that, following completion of the performance measurement period, 91.985% of
the award vests. 117,245 shares were therefore available for vest with the
remaining balance of shares, 10,216, lapsing with immediate effect.

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Smith & Nephew plc ordinary shares of USD 0.20 each

 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Final vest of a Performance Award granted on 29 April 2022 under the award
                                                              agreement.
 Date of Transaction                                          2022 - 12 - 08
 Place of Transaction                                         London Stock Exchange (XLON)

 

 Name                                  Price (£)   Volume                                                                      Aggregated information  Total Ordinary Share Holding following the transaction *  Total Ordinary Share Holding as a % of the Company's ISC following the

                                                                                                                                                                                   transaction *
 (Position)                  Status
 Deepak Nath                 Director  10.96       117,245 (of which 28,650 were sold to cover taxes due and 88,595 retained)  N/A Single Transaction  97,784.00000 ordinary shares                              0.01114%

 (Chief Executive Officer)

 

* including those held by Persons Closely Associated with the Director/PDMR.
All figures in these columns are stated to 5 decimal places where applicable.

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFLLFTLAIIF